Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-08
2011-03-08
Chu, Yong (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S227500, C514S235800, C514S254050, C514S326000, C514S217090
Reexamination Certificate
active
07902239
ABSTRACT:
The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
REFERENCES:
patent: 00/10563 (2000-03-01), None
patent: 02/057240 (2002-07-01), None
patent: 02/948814 (2002-11-01), None
Scheijen B. et al, Oncogene, 2002, vol. 21, p. 3314-3333.
Stirewalt et al. “The Role of FLT3 In Haematopoietic Malignancies”, Nature Reviews Cancer 3, 650-665, 2003.
Arnost Michael
Binch Hayley
Davies Robert J.
Forster Cornelia J.
Galullo Vincent
Chu Yong
Pearson Daniel A.
Vertex Pharmaceuticals Incorporated
LandOfFree
Diaminotriazoles useful as inhibitors of protein kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diaminotriazoles useful as inhibitors of protein kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diaminotriazoles useful as inhibitors of protein kinases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2719701